Biotechnology VALUE FUND L P, Director Other at Kymera Therapeutics, Inc. (KYMR), bought 10,100 shares at $14.00 ($141K) on 2022-05-20, disclosed to the SEC on 2022-05-24.
Open-market purchase of $141k KYMR by Director Other. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.00 | 37 | $518 | 0.4% |
| 2 | $14.00 | 4,180 | $59K | 41.4% |
| 3 | $14.00 | 5,883 | $82K | 58.2% |
| Total | $14.00 avg | 10,100 | $141K | 100% |
| Filing → |
| OLMA | BUY | 2021-12-02 | $13.9M | — | Filing → |
| KYMR | BUY | 2021-07-06 | $25.6M | — | Filing → |
| RAIN | BUY | 2021-07-06 | $15.7M | — | Filing → |